Market Place
Sourcing Support
Procaps Requests Hearing After Nasdaq Listing Determination
15 Nov 2024 //
GLOBENEWSWIRE
Procaps Issues Shareholder Letter Update
10 Oct 2024 //
GLOBENEWSWIRE
Procaps Issues Shareholder Letter Update
18 Sep 2024 //
GLOBENEWSWIRE
Procaps Issues Shareholder Letter
03 Sep 2024 //
GLOBENEWSWIRE
Procaps Group Announces New Chairman
28 Jun 2024 //
BUSINESSWIRE
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
20 May 2024 //
BUSINESSWIRE
Procaps Group Delays Filing of Annual Report on Form 20-F
14 May 2024 //
BUSINESSWIRE
Procaps Group Delays Filing of Annual Report on Form 20-F
01 May 2024 //
BUSINESSWIRE
Procaps Issues Shareholder Letter from New CEO
05 Feb 2024 //
BUSINESSWIRE
Procaps Group – Notice to Shareholders
16 Jan 2024 //
BUSINESSWIRE
Procaps Group Reports Third Quarter 2023 Results
26 Dec 2023 //
BUSINESSWIRE
Statement from the Board of Directors of Procaps Group
21 Dec 2023 //
BUSINESSWIRE
Procaps Group and Genomma Lab Announce a Strategic Agreement
29 Nov 2023 //
BUSINESSWIRE
Procaps Group Announces Appointment of Jose Antonio Vieira as CEO Starting 2024
22 Nov 2023 //
BUSINESSWIRE
Procaps Group Update on Third Quarter Results
14 Nov 2023 //
BUSINESSWIRE
Procaps Group to Report Third Quarter and Nine Months 2023 Results
10 Nov 2023 //
BUSINESSWIRE
Procaps Group Wins First Place in Ranking of Innovative Companies
30 Oct 2023 //
BUSINESSWIRE
Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors
23 Oct 2023 //
BUSINESSWIRE
Procaps Group to Participate at CPHI Barcelona 2023
16 Oct 2023 //
BUSINESSWIRE
CPHI Barcelona Sustainability Partner Interview – Procaps` improvement through innovation
09 Oct 2023 //
CPHI-ONLINE
On track at CPHI Barcelona - The Track Sponsor interview: Procaps
06 Oct 2023 //
CPHI-ONLINE
Procaps Group to Participate at BTG 2023 LatAm CEO Conference
15 Sep 2023 //
BUSINESSWIRE
Procaps Group Announces the Expansion of its Oncology Portfolio
07 Sep 2023 //
BUSINESSWIRE
Procaps Group Reports Second Quarter 2023 Results
05 Sep 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.